Abstract
Abstract
Background
Antimicrobial resistance (AMR) is accelerated by the widespread and often indiscriminate use of antimicrobials in humans, animals, and the environment. In 2015, the World Health Organization recognised AMR as one of the top ten global health threats, due to its potential to neutralise humanity’s advancements in western medicine by enabling the emergence of new strains of existing pathogens, many of which have no available treatments. Over the past decade, several countries, including those in low- and middle-income contexts, have started implementing interventions to tackle AMR. However, economic evidence regarding the cost-effectiveness of these interventions remains weak. To address this evidence gap, we will conduct a systematic literature review to provide a comprehensive summary on the value for money of different AMR interventions.
Methods
We aim to conduct a systematic literature review of all available economic evaluations on interventions addressing AMR and will provide a narrative synthesis of our findings. Systematic searches for relevant studies will be performed across all suitable databases as well as in grey literature sources such as unpublished studies, reports, and other relevant documents. All economic evaluation studies will be included as long as they report an economic outcome and have stated that the analysed intervention will reduce antimicrobial resistance or antimicrobial use in the abstract. Those studies reporting clinical endpoints alone will be excluded. Selection for final inclusion and data extraction will be performed by two independent reviewers.
Discussion
The review will be one of the first of its kind, and the most recent, to systematically review literature on the cost-effectiveness of AMR interventions, an important evidence gap in the economics of AMR. The findings will enable policy and decision-makers, particularly in resource-constrained settings, to better use available resources when selecting interventions to address AMR burdens,
Systematic review registration
PROSPERO CRD42020190310
Funder
Fleming Fund
Royal Society of Tropical Medicine and Hygiene
Bill and Melinda Gates Foundation
Department for International Development, UK Government
Rockefeller Foundation
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. World Health Organisation. Ten threats to global health in 2019. Published 2019. https://www.who.int/emergencies/ten-threats-to-global-health-in-2019
2. Jonas OB, Irwin A, Berthe FCJ, Le Gall FG, Marquez PV. Drug-resistant infections: a threat to our economic future (Vol. 2): final report (English). HNP/Agriculture Global Antimicrobial Resistance Initiative. Washington, DC: World Bank Group; 2017. http://documents.worldbank.org/curated/en/323311493396993758/final-report.
3. World Health Organization. What is antimicrobial resistance? https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance.
4. Centers for Disease Control and Prevention. Antibiotic-resistant gonorrhea. https://www.cdc.gov/std/gonorrhea/arg/default.htm.
5. Sharma A, Hill A, Kurbatova E, van der Walt M, Kvasnovsky C, Tupasi TE, et al. Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study. Lancet Infect Dis. 2017;17(7):707–15. https://doi.org/10.1016/S1473-3099(17)30247-5.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献